FDA inspection
Carter BloodCare - Baylor: FDA inspection ending Jul 25, 2019
FDA inspection 1098356 · Voluntary Action Indicated (VAI) · Dallas, TX
Key facts
| Inspection ID | 1098356 |
|---|---|
| Firm | Carter BloodCare - Baylor |
| FEI number | 1674451 |
| Address | 4201 Gaston Ave Ste 110 |
| City | Dallas |
| State | TX |
| ZIP | 75246 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Jul 25, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data